Novo Nordisk(NVO) - 2024 Q1 - Earnings Call Presentation

1 Investor presentation First three months of 2024 Novo Nordisk – a focused healthcare company Investor presentation First three months of 2024 ABIGAIL CONIAH RAFAEL VALVERDE Abigail lives with obesity Rafael lives with obesity United Kingdom Mexico Novo Nordisk® 2 Investor presentation First three months of 2024 Progress on Strategic Aspirations 2025 Agenda Commercial execution Agenda Innovation and therapeutic focus Financials Novo Nordisk® 3 Investor presentation First three months of 2024 Forward-lookin ...